2006
Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999-2000)*
Henrich JB, Hughes JP, Kaufman SC, Brody DJ, Curtin LR. Limitations of follicle-stimulating hormone in assessing menopause status: findings from the National Health and Nutrition Examination Survey (NHANES 1999-2000)*. Menopause The Journal Of The North American Menopause Society 2006, 13: 171-177. PMID: 16645530, DOI: 10.1097/01.gme.0000198489.49618.96.Peer-Reviewed Original ResearchConceptsFollicle-stimulating hormoneNutrition Examination SurveyMenopause transitionExamination SurveyNational HealthLevels of FSHMenopause transition stagesPopulation-based estimatesFSH levelsMenopause statusMultivariable analysisPostmenopausal stageNHANES 1999Postmenopause stagesUS womenCutoff pointWomenHormoneDifferent reproductive stagesConsiderable overlapRepresentative sampleAgeImportant determinantHealthLH
1999
Postmenopausal Estrogen Replacement Therapy Is Associated with Adverse Breast Cancer Prognostic Indices
LeBlanc ES, Viscoli CM, Henrich JB. Postmenopausal Estrogen Replacement Therapy Is Associated with Adverse Breast Cancer Prognostic Indices. Journal Of Women's Health 1999, 8: 815-823. PMID: 10495262, DOI: 10.1089/152460999319138.Peer-Reviewed Original ResearchConceptsEstrogen replacement therapyPrognostic indexERT usersTumor characteristicsPrognostic groupsReplacement therapyOdds ratioUsers of ERTPostmenopausal estrogen replacement therapyNegative estrogen receptor statusBiopsy-proven breast cancerFavorable tumor characteristicsBreast cancer patientsEstrogen receptor statusLong-term outcomesPoor prognostic groupTime of mammographyEarly-stage tumorsAdverse prognostic indexSelf-administered questionnairePositive nodesPostmenopausal womenERT useReceptor statusCancer patients
1998
Postmenopausal Estrogen Use and Invasive versus in situ Breast Cancer Risk
Henrich J, Kornguth P, Viscoli C, Horwitz R. Postmenopausal Estrogen Use and Invasive versus in situ Breast Cancer Risk. Journal Of Clinical Epidemiology 1998, 51: 1277-1283. PMID: 10086820, DOI: 10.1016/s0895-4356(98)00116-4.Peer-Reviewed Original ResearchConceptsBreast cancer riskInvasive breast cancerOverall odds ratioERT useBreast cancerCancer riskEstrogen replacement therapy usePostmenopausal women 45 yearsSitu breast cancer riskPostmenopausal estrogen useSitu breast cancerWomen 45 yearsCase-control studyLack of associationDistinct biological differencesEstrogen useTherapy useSitu diseaseInvasive diseaseOdds ratioInvasive tumorsRisk estimatesSmall sample sizeCancerPositive association